Participation by side
0 votes · 6 arguments · 1 take
Pro has more contributions. This is not a debate result.
Make your case in 60 seconds. 1 Pro · 0 Con.
Declare a side and become findable. When someone opens a matching seat, you hear about it first.
Pick your side
Schedule a round for a later date, or open a video room. Confirm an opponent and the format before starting. Signing in is required.
Live debate for the event "Should Defeating Aging Be a Civilizational Priority?" on superdebate.org.
Longevity research overwhelmingly benefits the wealthy. In a world where billions lack basic healthcare, redirecting billions toward life extension for those already living comfortably is a profound misallocation. The global disease burden from malaria, tuberculosis, and maternal mortality is not declining fast enough to justify diverting resources toward extending the lifespans of the already-healthy.
Longevity research has already produced interventions that extend healthspan — the period of healthy life, not just total lifespan — in model organisms. Rapamycin, senolytics, and caloric restriction mimetics show measurable effects. Dismissing the field as pursuit of immortality is a straw man of serious biology.
Finitude gives life urgency and meaning. Philosophical traditions from Stoicism to Buddhism treat mortality as a feature, not a bug — the awareness of death motivates connection, creativity, and priorities. The drive to escape death may reflect pathology rather than wisdom, and the resources devoted to it might better serve the living.
Extended lifespans exacerbate demographic crises already straining pensions, housing, and political power. Elderly populations concentrated at the top of wealth distributions would become even more dominant, making it harder for younger generations to innovate, accumulate assets, or reshape political institutions.
A meaningful delay in aging onset could save tens of trillions in healthcare costs and unlock decades of productive contribution from currently healthy older people. The fiscal and human case for funding this research is stronger than for most conditions that receive far more attention and funding.
Aging causes most of the 150,000 deaths daily — cancer, heart disease, neurodegeneration, immune decline are all downstream of biological aging. Treating aging as a disease rather than an inevitability is the most impactful medical priority imaginable. Every other cause of premature death is already pursued; this one is institutionally ignored.
Interested in debating this topic live? Tell us how you want to get involved — we reach out to every submission.
